search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
NEWS


Surgical Robot business raises $100 m in a Series B financing


CMR Surgical, a British company developing a next-generation surgical robot, has closed a Series B funding round raising $100 million from new investor, Zhejiang Silk Road Fund and existing investors Escala Capital Investments, LGT, Cambridge Innovation Capital and Watrium. CMR Surgical will use the proceeds to


prepare its Versius system for planned commercialisation. Activities will include the completion of validation studies for regulatory approval processes in both Europe and the USA, international expansion, and commercial scale-up in response to considerable industry interest in adoption of this new product. Inspired by the human arm, the Versius system’s compact size and dexterity means the system can be used across a wide range of minimal access procedures whilst retaining its portability. These are key attributes in delivering a system that can fit easily into hospital workflows, drive up utilisation and in turn help surgical robotics reach its full market potential for the benefits of patients around the world. The company is conducting preclinical


trials, demonstrating the ability of its Versius system to perform upper gastrointestinal, gynaecological, colorectal and renal surgery. Versius is said to represent a new paradigm in surgical experience for the industry, surgeons and patients. With Versius, CMR Surgical is targeting


the robot-assisted minimal access surgery market which, globally, is


£500,000 target hit for children’s heart theatre


The Children’s Heart Surgery Fund (CHSF) is celebrating after raising more than £500,000 to invest in its new heart theatre in Leeds. The ‘Keeping The Beat’ campaign was launched in 2016 and has since received overwhelming support. Work began on the state-of-the-art facility in February 2018 and it will open in early 2019, providing treatment for children and babies suffering from complex cardiac problems. The cardiac hybrid theatre allows


estimated to reach $20 billion by 2025. Martin Frost, chief executive officer


of CMR Surgical, said: “CMR Surgical’s rapid growth has given us the opportunity to develop a life-changing solution which we expect to change the take up of minimal access surgery worldwide. With these latest funds, we intend to start commercialising Versius in Europe, the USA and more broadly. The overwhelming financial backing from our existing and new investors, with strong participation from management and employees, demonstrates their enthusiasm and support for CMR Surgical’s vision in making minimal access surgery available to all.” The Series B financing was supported


by Perella Weinberg Partners advising the Company and Arion Capital advising ZUIG, managers of the Zhejiang Silk Road Fund.


from LAWTON Laparoscopic Instruments


Distributors for:


cardiac surgeons and cardiologists to perform surgery at the same time which means the skills of both specialists can be employed together, reducing treatment time for patients. The intra-operative MRI scanner allows scans to be done during neurological surgical procedures. For example, surgeons will be able to see straight away how much of a brain tumour has been removed rather than scanning at a later date to discover that additional procedures may be required. Patients need fewer general anaesthetics, MRI scans and surgical procedures. Carin van Doorn, head of congenital


cardiac surgery, said: “The new hybrid operating theatre will allow surgeons and catheter specialists to work together during operations, which will be of benefit particularly for complex and for high risk patients. We are thrilled to see the hybrid theatre being built now, and are extremely grateful to the CHSF and to all those amazing donors who are making this possible.”


The complete range of laparoscopic instruments in 3, 5 and 10mm diameter shaft. CATERHAM SURGICAL SUPPLIES LTD Unit 16, IO Centre Croydon Road, Croydon CR0 4WQ Tel: 020 8683 1103 l Fax: 020 8683 1105 l Email: martin@caterhamsurgical.co.uk l www.caterhamsurgical.co.uk OPERATING THEATRE l JULY 2018 l 7


CATALOGUES ON REQUEST


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64